Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years

Bone Marrow Transplantation volume 26, pages 999–1004 (2000)Cite this article

Abstract

Invasive fungal infections (IFI) with substantial mortality constitute an increasing problem among BMT patients. From 1986 to 1996 148 children underwent BMT, and are included in a retrospective analysis of the incidence, risk factors and outcome of IFI. By histopathology or culture-proven IFI (Candida, 10; Aspergillus, 8) was documented in 12/73 (16%) allogeneic and in 6/75 (8%) autologous BMT patients. Of these 18 patients, 15 subsequently died, and in 12 (66%) IFI was regarded as the main cause of death. In addition to the patients with documented IFI, 48 had suspected and 82 no fungal infection. Invasive candidal infections were more frequent in patients with semiquantitatively estimated abundant candidal colonization as compared with those with no colonization (18% vs 3%, P = 0.015). In the allogeneic group, 50% of those with severe (grades III–IV) aGVHD had IFI as opposed to 8% of those with no or mild aGVHD (P < 0.001). Regarding cGVHD, 57% of those with extensive cGVHD vs 5% of those with absent or limited cGVHD had IFI (P < 0.001). The dose of steroids was associated with IFI: 77% of those who received high-dose steroids (methylprednisolone 0.25–1 g/day for 5 days) vs 5% of those with conventional-dose (prednisone 2 mg/kg/day) had IFI (P < 0.001). Particularly for BMT patients at risk, new, quicker and better diagnostic tests and more effective anti-fungal agents, both for prophylaxis and treatment, are needed. Bone Marrow Transplantation (2000) 26, 999–1004.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Goodrich JM, Reed EC, Mori M et al. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation J Infect Dis 1991 164: 731–740

    Article  CAS  Google Scholar 

  2. Wald A, Leisenring W, van Burik JA, Bowden RA . Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation J Infect Dis 1997 175: 1459–1466

    Article  CAS  Google Scholar 

  3. Anttila VJ, Elonen E, Nordling S et al. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications Clin Infect Dis 1997 24: 375–380

    Article  CAS  Google Scholar 

  4. Verfaillie C, Weisdorf D, Haake R et al. Candida infections in bone marrow transplant recipients Bone Marrow Transplant 1991 8: 177–184

    CAS  PubMed  Google Scholar 

  5. Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant 1997 19: 801–808

    Article  CAS  Google Scholar 

  6. Morrison VA, Haake RJ, Weisdorf DJ . Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome Am J Med 1994 96: 497–503

    Article  CAS  Google Scholar 

  7. Chandrasekar PH, Weinmann A, Shearer C . Autopsy-identified infections among bone marrow transplant recipients: a clinico-pathologic study of 56 patients Bone Marrow Transplant 1995 16: 675–681

    CAS  PubMed  Google Scholar 

  8. Benhamou E, Hartmann O, Nogues C et al. Does ketokonazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial Bone Marrow Transplant 1991 7: 127–131

    CAS  PubMed  Google Scholar 

  9. Klingspor L, Stintzing G, Fasth A, Tollemar J . Deep Candida infection in children receiving allogeneic bone marrow transplants: incidence, risk factors and diagnosis Bone Marrow Transplant 1996 17: 1043–1049

    CAS  PubMed  Google Scholar 

  10. Mäkipernaa A, Saarinen UM, Siimes MA . Allogeneic bone marrow transplantation in children: single institution experience from 1974 to 1992 Acta Paediatr 1995 84: 683–688

    Article  Google Scholar 

  11. Hovi L, Lindqvist C, Donner U, Saarinen UM . Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy J Pediatr Hematol Oncol 1996 18: 90–94

    Article  CAS  Google Scholar 

  12. Sulahian A, Tabouret M, Ribaud P et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis Eur J Clin Microbiol Infect Dis 1996 15: 139–145

    Article  CAS  Google Scholar 

  13. Einsele H, Hebart H, Roller G et al. Detection and identification of fungal pathogens in blood by using molecular probes J Clin Microbiol 1997 35: 1353–1360

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Chanock SJ, Walsh TJ . Molecular diagnosis of Candida infection in the compromised host: current status and future prospects Int J Infect Dis 1997 1: 20–24

    Google Scholar 

  15. Ribaud P, Chastang C, Latge JP et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation Clin Infect Dis 1999 28: 322–330

    Article  CAS  Google Scholar 

  16. Riley DK, Pavia AT, Beatty PG et al. Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? Bone Marrow Transplant 1995 15: 469–473

    CAS  PubMed  Google Scholar 

  17. Hoppe JE, Klausner M, Klingebiel T, Niethammer D . Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients Mycoses 1997 40: 47–54

    Article  CAS  Google Scholar 

  18. Gotzshe PC, Johansen HK . Routine antifungal therapy in cancer patients. The Cochrane Database of Systematic Reviews. The Cochrane Library: Copenhagen, vol 3, 1998

  19. Bowden RA . Fungal infections after hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic Cell Transplantation Blackwell Science: Malden, MA pp 550–559

  20. Guiot HF, Fibbe WE, van ’t Wout JW . Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis Clin Infect Dis 1994 18: 525–532

    Article  CAS  Google Scholar 

  21. Martino P, Girmenia C, Micozzi A et al. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients Eur J Clin Microbiol Infect Dis 1994 13: 797–804

    Article  CAS  Google Scholar 

  22. O'Donnell MR, Schmidt GM, Tegtmeier BR et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients J Clin Oncol 1994 12: 827–834

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from the Nona and Kullervo Väre Foundation.

Author information

Authors and Affiliations

  1. Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland

    L Hovi, K Vettenranta & H Saxen

  2. Children's Hospital, University of Kuopio, Finland

    UM Saarinen-Pihkala

Authors
  1. L Hovi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. UM Saarinen-Pihkala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Vettenranta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Saxen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hovi, L., Saarinen-Pihkala, U., Vettenranta, K. et al. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 26, 999–1004 (2000). https://doi.org/10.1038/sj.bmt.1702654

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702654

Keywords

This article is cited by

Search

Advanced search

Quick links